Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/13/2022
China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
12/13/2022
CNIPA Issued Promotion Plan To Strengthen IP Protection (Mondaq)
12/13/2022
The "Unofficial" CN Orange Book User Guide For Pharmaceutical Patents ...
12/13/2022
Financing Rebounds for Chinese Drugmakers in November
12/12/2022
IQVIA: Chinese Retail Pharmacy Sales down 3.6% in MAT Q3/2022
12/12/2022
Sinohealth: Drug Sales of Chinese Retail Pharmacy Sector Up 3.8% in Fi...
12/9/2022
China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
12/9/2022
Drug R&D and Product Registration News Digest December 2022 (1)
12/8/2022
Sinopharm Considering Bid to Take China TCM for $4B: Bloomberg
12/8/2022
China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
12/8/2022
November Sees Several Approvals for China-developed Drugs (PharmaDJ)
12/7/2022
54 Drugs Greenlighted Since Conditional Approval Implemented in China ...
12/6/2022
NHSA Announces Postponement of On-Site Negotiations for the 2022 NRDL
12/6/2022
Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
12/5/2022
Incyte Forms Partnership with CMS for Ruxolitinib Cream in Greater Chi...
12/5/2022
Joint Fight Against Cancer Can Help Re-Energize U.S.-China Ties: Asia ...
12/2/2022
CDE Issues Notice on Requirements for e-Submission of Drug Registratio...
12/2/2022
Catalent Expands Clinical Supply Facility in China's FTZ
12/2/2022
HanAll's Licensed Partner in China Enters Sublicense Agreement with CS...
12/2/2022
Recent Executive Moves
12/2/2022
China's Challenge in the Drug Services Field (C&EN)
12/1/2022
A Growing Number of Drugmakers in China Are on A Quest to Treat NASH (...
12/1/2022
Eli Lilly Dumps Innovent's PD-1 after FDA Rebuff (FiercePharma)
12/1/2022
NMPA Solicits Comments on the Provisions on Facilitating Main Responsi...
11/30/2022
WuXi STA Launches Another Parenteral Formulation Manufacturing Line at...
11/30/2022
NMPA Issues Appendix 6 for Quality Control of Drug Retail Delivery of ...
11/30/2022
NMPA Issues the Announcement on Implementation of Electronic Submissio...
11/30/2022
NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
11/30/2022
NMPA Issues the Announcement on Regulating the Filing and Reporting of...
11/30/2022
XJTLU and University of Liverpool to Inaugurate Joint Pharma R&D Cente...
Page:
119
/
775
Total number of articles:
23233
:
[First]
[<<]
[117]
[118]
[119]
[120]
[121]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit